FactSet Research Systems Inc. Profile Avatar - Palmy Investing

FactSet Research Systems Inc.

FactSet Research Systems Inc., a financial data and analytics company, provides integrated financial information and analytical applications to the investment community in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company d…
Financial - Data & Stock Exchanges
US, Norwalk [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 83% Positive
Leverage & Liquidity 50% Balanced
Per Share Metrics 100% Best
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q2 Q3 Δ in %
EV/EBITDA -16.34 68.34 81.68
Graham Fair Price 8.54 68.09 62.73
PEG -65.62 2.00 -5.82
Price/Book -16.74 8.15 9.78
Price/Cash Flow -50.91 70.99 144.61
Prices/Earnings -22.14 24.34 31.26
Price/Sales -13.71 27.86 32.28
Price/FCF -50.91 70.99 144.61
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q2 Q3 Δ in %
Gross Profit Margin 3.84 0.55 0.53
Operating Margin 3.83 0.37 0.35
ROA 10.84 0.04 0.04
ROE 0.08 0.08 6.94
ROIC 0.05 0.05 3.52
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q2 Q3 Δ in %
Debt QOQ -0.04 -0.04 4.70
Dividends QOQ < 0.005 < 0.005 64.20
EBIT QOQ 0.02 0.05 160.73
EPS QOQ -0.05 0.12 126.45
FCF QOQ -0.12 0.78 543.62
Revenue QOQ < 0.005 0.01 80.12
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q2 Q3 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) < 0.005 0.00 inf
Days Sales Outstanding (DSO) 44.87 39.10 -12.87
Inventory Turnover 255142000.00 0.00 inf
Debt/Capitalization 0.46 0.44 -4.79
Quick Ratio 1.57 1.13 -27.77
Naive Interpretation member
04 - Leverage & Liquidity · Balanced
Fundamentals

Per Share Metrics

Metric Q2 Q3 Δ in %
Book Value 47.29 49.63 4.96
Cash 11.82 13.71 15.99
Capex -0.58 -0.56 2.60
Free Cash Flow 3.20 5.69 78.02
Revenue 14.33 14.51 1.28
Naive Interpretation member
05 - Per Share Metrics · Best
Fundamentals

Financial Health

Metric Q2 Q3 Δ in %
Current Ratio 1.79 1.28 -28.60
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 5.70 4.90 -14.11
Naive Interpretation Member
06 - Financial Health · Weak
End of FDS's Analysis
CIK: 1013237 CUSIP: 303075105 ISIN: US3030751057 LEI: - UEI: -
Secondary Listings
FDS has no secondary listings inside our databases.